MedTrace Logo

Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening

NCT02927561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2016-10-07

No results posted yet for this study

Summary

In Brazil 10% of the adult population has diabetes. Of these, 39.0% are undiagnosed, at risk for developing complications such as diabetic retinopathy (DR). Due to the increasing prevalence of diabetes and high percentage of patients with uncontrolled disease, cost-effective tools are needed with focused attention on diabetes prevention and management in the current health system. The automatic retinopathy detection can enlarge the screening, reducing the workload and costs compared to manual image graders.

Conditions

Interventions

OTHER

Diabetic Retinopathy screening

Diabetic Retinopathy screening

Sponsors & Collaborators

  • Retina Clinic, Sao Paulo, Brazil

    lead OTHER

Principal Investigators

  • Gabriel Andrade, M.D. · Research Director

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-06-30
Completion
2016-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927561 on ClinicalTrials.gov